Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.


Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Multicentric reticulohistiocytosis

See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.


Newline Maker

What is the prognosis for individuals with multicentric reticulohistiocytosis?

After an average course of 8 years, patients often go into remission (a state where symptoms have subsided). The disease can cause considerable morbidity (disability as a result of the disease), mainly related to the occurrence of severe arthritis. The arthritis can come and go, but it can be very severe in about 45% of cases.[1] If the patient has an associated cancer, the prognosis relates to that of the specific cancer.[2]
Last updated: 6/21/2013

  1. Rapini RP, Morgan LT. Dermatologic Manifestations of Multicentric Reticulohistiocytosis . Medscape Reference . June 6, 2012; Accessed 9/28/2012.
  2. Callen JP. Multicentric Reticulohistiocytosis. Medscape Reference. August 16, 2011; Accessed 9/28/2012.